Pembrolizumab improves survival in non-squamous NSCLC

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2018年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1306 / 1306
页数：1
相关论文
共 50 条
  • [41] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] KRAS molecular profiling in non-squamous non-small cell lung cancer (NSCLC).
    Karim, Nagla Abdel
    Starnes, Sandra
    Morris, John
    Pathrose, Peter
    Perry, Ashley
    Fathallah, Hassana
    CLINICAL CANCER RESEARCH, 2014, 20
  • [43] Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumab
    Shang, Xiaoling
    Li, Zhenxiang
    Sun, Jian
    Zhao, Chenglong
    Lin, Jiamao
    Wang, Haiyong
    LUNG CANCER, 2021, 154 : 105 - 112
  • [44] Efficacy of Pembrolizumab Plus Pemetrexed in Older Patients with Non-squamous NSCLC According to PDL1 Status from the CJLSG1901 Study
    Kogure, Y.
    Hashimoto, H.
    Ikeda, S.
    Harada, T.
    Hino, A.
    Miura, S.
    Goto, Y.
    Fujiwara, K.
    Kaktakami, N.
    Kubota, K.
    Murata, N.
    Mori, M.
    Abe, T.
    Yamamoto, N.
    Saka, H.
    Kondo, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S395 - S396
  • [45] Audit of safety and tolerability of combination platinum-pemetrexed-pembrolizumab in advanced non-squamous NSCLC in the real-world setting of a UK Cancer Centre
    Bhalla, N.
    Ghoz, H.
    LUNG CANCER, 2020, 139 : S53 - S54
  • [46] Survival and staging characteristics for non-squamous cell malignancies of the maxillary sinus
    Bhattacharyya, N
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (03) : 334 - 337
  • [47] Rechallenge with pemetrexed- based chemotherapy improves the survival of patients with advanced non-squamous non-small-cell lung cancer
    Zhuo, Ming-Lei
    Bai, Hua
    Wang, Zhi-Jie
    Duan, Ran-Chun
    An, Tong-Tong
    Wu, Mei-Na
    Zhao, Jun
    Wang, Yu-Yan
    Wang, Shu-Hang
    Wang, Jie
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 953 - 959
  • [48] Mutation analysis and association with TTF1 expression in lung non-squamous NSCLC
    Kret, A.
    Clark, C.
    Tennant, S.
    Nicolson, M.
    Kerr, K. M.
    LUNG CANCER, 2015, 87 : S16 - S16
  • [49] TRANSLATIONAL ENDPOINTS ASSOCIATED WITH STK11 MUTATIONS IN PATIENTS WITH NON-SQUAMOUS NSCLC
    Wu, Song
    Standifer, Nathan
    de los Reyes, Melissa
    Oberst, Micheal
    Raja, Rajv
    Barrett, Carl
    Ascierto, Maria
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A168 - A168
  • [50] Maintenance Therapy in advanced, non-squamous NSCLC Possibility of prolongued Tumor Controll with Pemetrexed
    不详
    ONKOLOGIE, 2012, 35 (06): : 390 - 391
12345